| Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 8.30 mm | 8.30 mm | 8.30 mm | 8.30 mm | 8.30 mm | 8.30 mm |
| Cash burn (monthly) | 2.17 mm | 2.68 mm | 419.67 k | 2.23 mm | 1.21 mm | 2.15 mm |
| Cash used (since last report) | 9.33 mm | 11.55 mm | 1.81 mm | 9.60 mm | 5.22 mm | 9.28 mm |
| Cash remaining | -1.03 mm | -3.25 mm | 6.49 mm | -1.30 mm | 3.08 mm | -976.22 k |
| Runway (months of cash) | -0.5 | -1.2 | 15.5 | -0.6 | 2.5 | -0.5 |
| 13F holders | Current |
|---|---|
| Total holders | 69 |
| Opened positions | 21 |
| Closed positions | 6 |
| Increased positions | 17 |
| Reduced positions | 16 |
| 13F shares | Current |
|---|---|
| Total value | 85.30 bn |
| Total shares | 14.40 mm |
| Total puts | 41.70 k |
| Total calls | 198.20 k |
| Total put/call ratio | 0.2 |
| Largest owners | Shares | Value |
|---|---|---|
| Rosalind Advisors | 2.65 mm | $21.20 bn |
| AIGH Capital Management | 1.78 mm | $16.10 bn |
| Vivo Opportunity Fund | 1.71 mm | $17.86 mm |
| Hirschman Orin | 1.54 mm | $6.25 mm |
| Vanguard | 1.11 mm | $10.03 bn |
| Biotechnology Value Fund L P | 1.04 mm | $10.89 mm |
| Vivo Capital | 997.01 k | $9.00 bn |
| Essex Investment Management | 336.72 k | $3.04 bn |
| Renaissance Technologies | 311.80 k | $2.82 bn |
| Geode Capital Management | 251.90 k | $2.28 bn |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 7 Feb 25 | Michel Gerard J | Stock Option Common Stock | Grant | Acquire A | No | No | 16.25 | 390,000 | 6.34 mm | 390,000 |
| 7 Feb 25 | Vojo Vukovic | Stock Option Common Stock | Grant | Acquire A | No | No | 16.25 | 113,000 | 1.84 mm | 113,000 |
| 7 Feb 25 | Martha S. Rook | Stock Option Common Stock | Grant | Acquire A | No | No | 16.25 | 113,000 | 1.84 mm | 113,000 |
| 7 Feb 25 | Kevin Muir | Stock Option Common Stock | Grant | Acquire A | No | No | 16.25 | 113,000 | 1.84 mm | 113,000 |
| 7 Feb 25 | Sandra Pennell | Stock Option Common Stock | Grant | Acquire A | No | No | 16.25 | 113,000 | 1.84 mm | 113,000 |
